T-Lymphocyte Activation Antigen CD86 (CD86) Antibody

Este producto es parte de CD86 molecule
Product Graph
260€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
T-Lymphocyte Activation Antigen CD86 (CD86) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx421443
tested applications
FCM

Description

T-Lymphocyte Activation Antigen CD86 (CD86) Antibody is a Mouse Monoclonal antibody for the detection of T-Lymphocyte Activation Antigen CD86 (CD86) in Human samples.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
T-Lymphocyte Activation Antigen CD86 (CD86)
Host
Mouse
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1 Kappa
Clone ID
V991
Purity
> 95%
Purification
Purified by Protein A/G affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
FCM
Buffer
0.01 M PBS, pH 7.4.
Availability
Shipped within 5-12 working days.
Storage
Store at 4 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C or -80 °C for long-term storage. Avoid repeated freeze-thaw cycles.
Dry Ice
No
UniProt ID
P42081
Gene ID
942
NCBI Accession
NP_001193853.1
Alias
B70,B7-2,B7.2,LAB72,CD28LG2,Activation B7-2 antigen,BU63,CTLA-4 counter-receptor B7.2,FUN-1,T-lymphocyte activation antigen CD86
Background
Antibody anti-CD86
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

Related Products

EB0043

Bovine CD86(cluster of differentiation 86) ELISA Kit

Ver Producto
EH0659

Human CD86(T-lymphocyte activation antigen CD86) ELISA Kit

Ver Producto
FNab01504

anti- CD86 antibody

Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation. (Microbial infection) Acts as a receptor for adenovirus subgroup B.

Ver Producto